James Gilligan

James Gilligan

Presidente presso
Tryp Therapeutics, Inc.
74 anni
Health Technology
Consumer Services
Commercial Services

Profilo

James Patrick Gilligan was the founder of Unigene Laboratories, Inc. (founded in 1981) where he held the title of Vice President-Product Development.
He was also the founder of Herborium Group, Inc. (founded in 2002) where he held the titles of Co-President, Chief Operating Officer & Director.
Additionally, he was the founder of Tarsa Therapeutics, Inc. (founded in 2009) where he held the title of Chief Scientific Officer.
Dr. Gilligan is also the founder of The Bracken Group LLC.
Dr. Gilligan's current job is as the President & Chief Scientific Officer at Tryp Therapeutics, Inc. (since 2020).
His former jobs include being the Managing Partner at Solenture LLC (2018-2020) and the Principal at Taurus Development Group, Inc. (2018-2019).
In terms of education, Dr. Gilligan attended Bates College for his undergraduate degree, Seton Hall University for his graduate degree, and the University of Connecticut for his doctorate.

Posizioni attive di James Gilligan

SocietàPosizioneInizio
Presidente 01/11/2020

Precedenti posizioni note di James Gilligan

SocietàPosizioneFine
HERBORIUM GROUP, INC. Fondatore 01/06/2022
Corporate Officer/Principal 01/11/2020
Corporate Officer/Principal 01/12/2019
Fondatore 01/02/2018
Fondatore -
Vedi nel dettaglio l'esperienza di James Gilligan

Formazione di James Gilligan

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

6

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Industrial Services

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. James Gilligan